Fluid biomarkers in Alzheimer's disease
Joel Simrén(University of Gothenburg), Henrik Zetterberg(University of Wisconsin–Madison), Kaj Blennow(Sahlgrenska University Hospital), Anders Elmgren(AstraZeneca (Netherlands))
Cited by 52
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k